GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » ROE % Adjusted to Book Value

Par Drugs and Chemicals (NSE:PAR) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals ROE % Adjusted to Book Value?

Par Drugs and Chemicals's ROE % for the quarter that ended in Dec. 2024 was 2.39%. Par Drugs and Chemicals's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Par Drugs and Chemicals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Par Drugs and Chemicals ROE % Adjusted to Book Value Historical Data

The historical data trend for Par Drugs and Chemicals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals ROE % Adjusted to Book Value Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 28.50 17.14 5.01 7.14 5.96

Par Drugs and Chemicals Quarterly Data
Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.60 - 12.04 -

Competitive Comparison of Par Drugs and Chemicals's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's ROE % Adjusted to Book Value falls into.


;
;

Par Drugs and Chemicals ROE % Adjusted to Book Value Calculation

Par Drugs and Chemicals's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.49% / 3.10
=5.96%

Par Drugs and Chemicals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.39% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Par Drugs and Chemicals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.